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Editorial
‘‘Foreword’’
It is very honor for me to describe ‘‘Foreword’’ of the ﬁrst Journal of Arrhythmia as an
oﬃcial publication of Japanese Heart Rhythm Society. The title of this society changed
ﬁrstly from Japanese Pacemaker Committee to Japanese Society of Cardiac Pacing and
Electrophysiology, and for this time changed into Japanese Heart Rhythm Society. In 1977,
Japanese Pacemaker Committee held the ﬁrst open seminar only for pacemaker. Following
North American Society of Pacing and Electrophysiology (NASPE) started in 1980,
Japanese Society of Cardiac Pacing and Electrophysiology (JASPE) started in 1984. The
oﬃcial journal of NASPE was ‘‘PACE’’. The oﬃcial Journal of JASPE was ‘‘Cardiac
Pacing’’. Following this, the title of Japanese journal changed into ‘‘Journal of Arrhythmia’’
in 1998. NASPE changed its title into ‘‘Heart Rhythm Society (HRS)’’ in 2005, and then
JASPE changed its title into ‘‘Japanese Heart Rhythm Society (JHRS)’’ in 2006. HRS
changed the journal title into ‘‘Heart Rhythm’’. However, JHRS did not change the journal
title ‘‘Journal of Arrhythmia’’.
From August in 2005, Japanese ‘‘Journal of Arrhythmia’’ was published in English, rather
than Japanese. For example, if one doctor discovered the new therapeutics, he can cure 100
patients. If he published the new therapeutics in Japanese, 1,000 Japanese doctors can cure
100,000 patients. If he published the new therapeutics in English, 100,000 doctors can cure
1,000,000 patients. Therefore, the doctor should publish his new personal invention
especially in English.
In 1973, my colleague got a J-lead (American Pacemaker Corporation Inc.). However, we
could not implant J-lead to patient 2 years, because nobody knew the prognosis of atrial
pacing by J-lead. In 1975, we met the patient with sick sinus syndrome and Parkinson
syndrome. He could not discharge due to Parkinson syndrome. Therefore, we implanted J-
lead and followed-up precisely in the hospital. Then we got good results. We reported it on
the ﬁrst open seminar held by Japanese pacemaker committee in 1976. After that, many J-
leads were implanted and physiological pacing developed. The VVI pacing can prevent
syncope for SSS patient, but can not prevent palpitation due to bigeminy of own and pacing
rhythm. The AAI pacing can prevent palpitation completely and make a patient
comfortable.
In 1986, I visited to professor Cox in order to observe the arrhythmic surgery. At that
time Cox performed the second maze procedure under the top secret. In 1991, Cox reported
the maze procedure for isolated atrial ﬁbrillation. In 1992, I performed the maze procedure
for atrial ﬁbrillation (af) associated with mitral valve disease. In 1994, I reported that the
maze procedure was also good for af with mitral valve disease. Then the maze procedures
for af with mitral valve disease were performed popularly in the world. In Japan, about
10,000 patients received maze procedure. These results developed the catheter ablation.
My hope is that after the society has renamed ‘‘Japanese Heart Rhythm Society’’, all
categories not only pacing but also any arrhythmia shall develop more in future.
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